BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38186937)

  • 21. Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients.
    Christensen AM; Pauley JL; Molinelli AR; Panetta JC; Ward DA; Stewart CF; Hoffman JM; Howard SC; Pui CH; Pappo AS; Relling MV; Crews KR
    Cancer; 2012 Sep; 118(17):4321-30. PubMed ID: 22252903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
    Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.
    Ibarra M; Combs R; Taylor ZL; Ramsey LB; Mikkelsen T; Buddington RK; Heldrup J; Barreto JN; Guscott M; Lowe J; Hurmiz C; Marada S; Howard SC; Schaiquevich P
    Br J Clin Pharmacol; 2023 Feb; 89(2):660-671. PubMed ID: 35998099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of drug interaction between levetiracetam and high-dose methotrexate in patients with lymphoma.
    DeFino CE; Barreto JN; Pawlenty AG; Ruff MW; Carabenciov ID; Mara KC; Thompson CA
    Pharmacotherapy; 2021 May; 41(5):430-439. PubMed ID: 33655525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Patients with Acute Methotrexate Nephrotoxicity with High-Dose Leucovorin.
    Flombaum CD; Liu D; Yan SQ; Chan A; Mathew S; Meyers PA; Glezerman IG; Muthukumar T
    Pharmacotherapy; 2018 Jul; 38(7):714-724. PubMed ID: 29863765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase.
    Chan BS; Bosco AA; Buckley NA
    Br J Clin Pharmacol; 2024 Jun; ():. PubMed ID: 38889902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
    Barakat S; Assem H; Salama M; Mikhael N; El Chazli Y
    J Egypt Natl Canc Inst; 2022 Apr; 34(1):17. PubMed ID: 35434757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
    Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients.
    Wang Y; Wei L; Guan Y; Wang Q; Xie Q; Hao C
    Ren Fail; 2020 Nov; 42(1):1111-1117. PubMed ID: 33164656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
    Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
    Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.
    Winter SS; Dunsmore KP; Devidas M; Wood BL; Esiashvili N; Chen Z; Eisenberg N; Briegel N; Hayashi RJ; Gastier-Foster JM; Carroll AJ; Heerema NA; Asselin BL; Gaynon PS; Borowitz MJ; Loh ML; Rabin KR; Raetz EA; Zweidler-Mckay PA; Winick NJ; Carroll WL; Hunger SP
    J Clin Oncol; 2018 Oct; 36(29):2926-2934. PubMed ID: 30138085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of
    Yang FF; Xue TL; Gao C; Wu Y; Lin W; Li J; Zhang RD; Zheng HY; Liu SG
    Pharmacogenomics; 2022 Oct; 23(15):821-834. PubMed ID: 36193736
    [No Abstract]   [Full Text] [Related]  

  • 33. Outpatient administration of high-dose methotrexate in adults without drug monitoring - a case-control study of risk factors for acute kidney injury.
    Alves C; Pereira J; Rego EM; Rocha V; Silva WF
    Hematol Transfus Cell Ther; 2023 Dec; ():. PubMed ID: 38233304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding and managing methotrexate nephrotoxicity.
    Widemann BC; Adamson PC
    Oncologist; 2006 Jun; 11(6):694-703. PubMed ID: 16794248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Risk Factors in High-Dose Methotrexate-Induced Acute Kidney Injury in Childhood Acute Lymphoblastic Leukemia.
    Cheng DH; Lu H; Liu TT; Zou XQ; Pang HM
    Chemotherapy; 2018 Apr; 63(2):101-107. PubMed ID: 29672292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creatinine clearance rate and serum creatinine concentration are related to delayed methotrexate elimination in children with lymphoblastic malignancies.
    Mao J; Zhang L; Shen H; Tang Y; Song H; Zhao F; Xu W
    Neoplasma; 2014; 61(1):77-82. PubMed ID: 24195512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing delayed high-dose methotrexate excretion and its correlation with adverse reactions after treatment in children with malignant hematological tumors.
    Yu L; Shen J; Li H; Zhang M; Wang Z; Gao Y; Chen J; Li J
    Transl Pediatr; 2024 Feb; 13(2):300-309. PubMed ID: 38455749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours.
    Panetta JC; Roberts JK; Huang J; Lin T; Daryani VM; Harstead KE; Patel YT; Onar-Thomas A; Campagne O; Ward DA; Broniscer A; Robinson G; Gajjar A; Stewart CF
    Br J Clin Pharmacol; 2020 Feb; 86(2):362-371. PubMed ID: 31657864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
    Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.
    Krause AS; Weihrauch MR; Bode U; Fleischhack G; Elter T; Heuer T; Engert A; Diehl V; Josting A
    Leuk Lymphoma; 2002 Nov; 43(11):2139-43. PubMed ID: 12533039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.